Remdesivir is a broad-spectrum antiviral drug which is currently in phase 2 clinical trial for the treatment of Ebola.
If you want to change selection, open document below and click on "Move attachment"
Unknown titleshed last month, researchers from the National Institutes of Health, U.S., have shown that Remdesivir was able to treat four African green monkeys which were given a lethal dose of Nipah virus. <span>Remdesivir is a broad-spectrum antiviral drug which is currently in phase 2 clinical trial for the treatment of Ebola. Eight monkeys were inoculated with a lethal dose of Nipah virus Bangladesh strain, and, 24 hours later, four of them were treated intravenously with the drug for 12 consecutive days. Re Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details